Its price/earnings ratio sits at 18.12, lower than many growth-focused healthcare peers. Interestingly, CSL's reported earnings per share (EPS) in this snapshot is negative, which doesn't mathematically square with a positive P/E ratio.
Health
CSL vs Pro Medicus: Which ASX healthcare share is better?
Summarized version
CSL's divisions include CSL Behring, Seqirus, and Vifor. For dividend hunters, Pro Medicus pays out a much smaller yield of 0.43%, with a dividend of $0.69 per share.
The report’s most important sentence, shortened and in plain words. How
From the report
Headline check
All two things this headline claims are in the report.
Figures, names and quoted words in the headline, looked for in the report itself — not in the summary above. How this is checked
This is a summary. The indicators are not. Every score on this page was measured over the full 668-word report, which is the only way the numbers mean anything.
How this outlet filed it, and how we rewrote it
No other newsroom we read has filed on this event, so there is nothing to compare it with yet.
| Outlet | Niral Score |
|---|---|
| The Motley Fool Australiaas they published this story | 17.7 |
How did this read?
Sign in to react.
Comments
Comments are not open yet. They will be once there is someone to read every one before it appears. If something here is wrong, tell us — that we do read.
Report a problem with these scores or this rewrite — it goes straight into the public ledger.